Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Patent
1993-04-15
1995-10-24
Lacey, David L.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds expression product or fragment thereof of...
4241391, 4241521, 4241551, 4241581, A61K 39395
Patent
active
054608015
ABSTRACT:
The present invention discloses anti-bombesin monoclonal antibody and a method of detecting autocrine growth factor. A method and kit for screening and controlling growth of human SCLC has also been disclosed.
REFERENCES:
Waldman Science 252: 1657-1662 (1991).
Cuttitta et al. Nature 316: 823-826 (1985).
Moody et al. Science 214: 1246-1248 (1981).
Cuttitta et al. Clinical Research 31: 405A (1983).
Moody Peptides 4: 683-686 (1983).
Cuttitta et al. Monoclonal Antibodies in Cancer pp. 161-180 (1984).
Osband et al. Immunol. Today 11: 193-195 (1990).
Steiner et al. Biotechnology 11: 644 (1993).
Harris et al. Tibtech 11: 42-44 (1993).
Goding in Monoclonal Antibodies: Principles and Practice Academic Press, 1983 pp. 56-97.
Cuttitta et al., Science 158: 1570-1574 (1967).
Cuttitta Frank F.
Minna John D.
Gambel Phillip
Lacey David L.
The United States of America as represented by the Department of
LandOfFree
Inhibition of small cell lung cancer cell growth in vivo using m does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of small cell lung cancer cell growth in vivo using m, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of small cell lung cancer cell growth in vivo using m will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1884886